BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 11035725)

  • 1. The Cryptococcus neoformans gene DHA1 encodes an antigen that elicits a delayed-type hypersensitivity reaction in immune mice.
    Mandel MA; Grace GG; Orsborn KI; Schafer F; Murphy JW; Orbach MJ; Galgiani JN
    Infect Immun; 2000 Nov; 68(11):6196-201. PubMed ID: 11035725
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification and cloning of a cryptococcal deacetylase that produces protective immune responses.
    Biondo C; Beninati C; Delfino D; Oggioni M; Mancuso G; Midiri A; Bombaci M; Tomaselli G; Teti G
    Infect Immun; 2002 May; 70(5):2383-91. PubMed ID: 11953374
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Liposomes, a potential immunoadjuvant and carrier for a cryptococcal vaccine.
    Lambros MP; Schafer F; Blackstock R; Murphy JW
    J Pharm Sci; 1998 Sep; 87(9):1144-8. PubMed ID: 9724568
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of a third-order suppressor T cell (Ts3) induced by cryptococcal antigen(s).
    Khakpour FR; Murphy JW
    Infect Immun; 1987 Jul; 55(7):1657-62. PubMed ID: 2954914
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of immunization with Cryptococcus neoformans cells or cryptococcal culture filtrate antigen on direct anticryptococcal activities of murine T lymphocytes.
    Muth SM; Murphy JW
    Infect Immun; 1995 May; 63(5):1645-51. PubMed ID: 7729868
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clearance of Cryptococcus neoformans from immunologically suppressed mice.
    Murphy JW
    Infect Immun; 1989 Jul; 57(7):1946-52. PubMed ID: 2499541
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mobility of human neutrophils in response to Cryptococcus neoformans cells, culture filtrate antigen, and individual components of the antigen.
    Dong ZM; Murphy JW
    Infect Immun; 1993 Dec; 61(12):5067-77. PubMed ID: 8225584
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cellular immunity in a cutaneous model of cryptococcosis.
    Domer JE; Lyon FL; Murphy JW
    Infect Immun; 1983 Jun; 40(3):1052-9. PubMed ID: 6343238
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antigen-induced protective and nonprotective cell-mediated immune components against Cryptococcus neoformans.
    Murphy JW; Schafer F; Casadevall A; Adesina A
    Infect Immun; 1998 Jun; 66(6):2632-9. PubMed ID: 9596727
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serological, electrophoretic, and biological properties of Cryptococcus neoformans antigens.
    Murphy JW; Mosley RL; Cherniak R; Reyes GH; Kozel TR; Reiss E
    Infect Immun; 1988 Feb; 56(2):424-31. PubMed ID: 3123390
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of the two varieties of Cryptococcus neoformans cells and culture filtrate antigens on neutrophil locomotion.
    Dong ZM; Murphy JW
    Infect Immun; 1995 Jul; 63(7):2632-44. PubMed ID: 7790079
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CD8 cells play a critical role in delayed type hypersensitivity to intact Cryptococcus neoformans.
    Mody CH; Paine R; Jackson C; Chen GH; Toews GB
    J Immunol; 1994 Apr; 152(8):3970-9. PubMed ID: 8144964
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cloning and molecular characterization of CnTEF1 which encodes translation elongation factor 1alpha in Cryptococcus neoformans.
    Thornewell SJ; Peery RB; Skatrud PL
    Fungal Genet Biol; 1997 Oct; 22(2):84-91. PubMed ID: 9367655
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differences in components at delayed-type hypersensitivity reaction sites in mice immunized with either a protective or a nonprotective immunogen of Cryptococcus neoformans.
    Nichols KL; Bauman SK; Schafer FB; Murphy JW
    Infect Immun; 2002 Feb; 70(2):591-600. PubMed ID: 11796587
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Age-related resistance of C57BL/6 mice to Cryptococcus neoformans is dependent on maturation of NKT cells.
    Blackstock R; Murphy JW
    Infect Immun; 2004 Sep; 72(9):5175-80. PubMed ID: 15322012
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cryptococcal culture filtrate antigen for detection of delayed-type hypersensitivity in cryptococcosis.
    Murphy JW; Pahlavan N
    Infect Immun; 1979 Jul; 25(1):284-92. PubMed ID: 383616
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of cellular infiltrates and cytokine production during the expression phase of the anticryptococcal delayed-type hypersensitivity response.
    Buchanan KL; Murphy JW
    Infect Immun; 1993 Jul; 61(7):2854-65. PubMed ID: 8514388
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MIP-1 alpha contributes to the anticryptococcal delayed-type hypersensitivity reaction and protection against Cryptococcus neoformans.
    Doyle HA; Murphy JW
    J Leukoc Biol; 1997 Feb; 61(2):147-55. PubMed ID: 9021919
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transfer of immunity to cryptococcosis by T-enriched splenic lymphocytes from Cryptococcus neoformans-sensitized mice.
    Lim TS; Murphy JW
    Infect Immun; 1980 Oct; 30(1):5-11. PubMed ID: 7002791
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of a cell population which amplifies the anticryptococcal delayed-type hypersensitivity response.
    Fidel PL; Murphy JW
    Infect Immun; 1990 Feb; 58(2):393-8. PubMed ID: 2105273
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.